Why more doctors should pursue business and leadership training
“Just as medicine has its own language, so does business,” two surgeons explained in a new editorial.
Related Articles
Robotic heart surgery represents a key step forward for SS Innovations
The company’s SSi Mantra 3 robotic surgery system has already gained regulatory approvals in several countries. FDA approval is anticipated by late 2025 or early 2026.
Robotic heart surgery represents a key step forward for SS Innovations
The company’s SSi Mantra 3 robotic surgery system has already gained regulatory approvals in several countries. FDA approval is anticipated by late 2025 or early 2026.
Cardiology societies should develop separate guidelines for treating female heart patients
Janet Wei, MD, examined the key differences between men and women when it comes to cardiovascular disease. These differences, she said, highlight why female patients…
Late-breaking clinical trials announced for New York Valves 2025
The three-day event is now in its second year. Each day will feature late-breaking clinical trials focused on a different heart valve.
Atraverse Medical raises $29M to support FDA-approved heart tech
The San Diego-based startup gained FDA approval for its Hotwire RF guidewire in 2024. The technology has already been used to perform hundreds of heart…
AMA House of Delegates helps cardiology groups influence healthcare policies
American College of Cardiology Board of Trustees Chair David E. Winchester, MD, MS, examines the many benefits of working with with the American Medical Association…
Eli Lilly to acquire gene-editing specialists focused on CVD for up to $1.3B
The company has agreed to acquire Verve Therapeutics for an upfront payment of approximately $1 billion. The total could increase significantly, however, if certain milestones…
Q&A: Cardiologist and EARLY TAVR co-author questions study’s execution
The EARLY TAVR clinical trial made a significant impact, paving the way for the FDA to approve multiple transcatheter heart valves for the treatment of…
FDA clears blood clot removal system for treating pulmonary embolism
The Aventus Thrombectomy System was already cleared to treat blood clots in the peripheral arteries. This latest approval comes after positive results from an IDE…
Next-day discharge after TAVR is still safe when alternative access is required
Even TAVR patients not treated using transfemoral access can typically go home the very next day.